九洲药业：甲苯磺酸艾多沙班化学原料药上市申请获批准

Core Viewpoint - The company, Jiuzhou Pharmaceutical, has received approval from the National Medical Products Administration for the marketing application of Tofisopam Tosylate, an oral anticoagulant drug [1] Group 1: Company Information - Jiuzhou Pharmaceutical (603456.SH) announced the receipt of the marketing approval notification for Tofisopam Tosylate [1] - Tofisopam Tosylate is primarily used for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, as well as for the treatment or prevention of deep vein thrombosis and pulmonary embolism [1]